Cargando…

Higher Risk of Chronic Hepatitis E Virus Infection in Patients with Human Immunodeficiency Virus-1: An Iranian Cross-sectional Study

BACKGROUND & OBJECTIVE: Occurrence of Hepatitis E Virus (HEV) infection may be common in Human Immunodeficiency Virus (HIV-1) patients and may lead to chronic infection as well as cirrhosis. We intended to determine the incidence of HEV infection among HIV-1 patients compared to individuals with...

Descripción completa

Detalles Bibliográficos
Autores principales: Zahedi, Mohammad Javad, Shafieipour, Sara, Hayatbakhsh Abassi, Mohammad Mahdi, Pourjamali, Nader, Nakhaie, Mohsen, Charostad, Javad, Rezaei Zadeh Rukerd, Mohammad, Lashkarizadeh, Mohammad Mehdi, Karami Robati, Fatemeh, Dehghani, Azam, Jahani, Yunes, Arabzadeh, Seyed Ali Mohammad, Mollaei, Hamid Reza, Ranjbar, Ebrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Society of Pathology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439753/
https://www.ncbi.nlm.nih.gov/pubmed/37600571
http://dx.doi.org/10.30699/IJP.2023.551657.2870
_version_ 1785093020115271680
author Zahedi, Mohammad Javad
Shafieipour, Sara
Hayatbakhsh Abassi, Mohammad Mahdi
Pourjamali, Nader
Nakhaie, Mohsen
Charostad, Javad
Rezaei Zadeh Rukerd, Mohammad
Lashkarizadeh, Mohammad Mehdi
Karami Robati, Fatemeh
Dehghani, Azam
Jahani, Yunes
Arabzadeh, Seyed Ali Mohammad
Mollaei, Hamid Reza
Ranjbar, Ebrahim
author_facet Zahedi, Mohammad Javad
Shafieipour, Sara
Hayatbakhsh Abassi, Mohammad Mahdi
Pourjamali, Nader
Nakhaie, Mohsen
Charostad, Javad
Rezaei Zadeh Rukerd, Mohammad
Lashkarizadeh, Mohammad Mehdi
Karami Robati, Fatemeh
Dehghani, Azam
Jahani, Yunes
Arabzadeh, Seyed Ali Mohammad
Mollaei, Hamid Reza
Ranjbar, Ebrahim
author_sort Zahedi, Mohammad Javad
collection PubMed
description BACKGROUND & OBJECTIVE: Occurrence of Hepatitis E Virus (HEV) infection may be common in Human Immunodeficiency Virus (HIV-1) patients and may lead to chronic infection as well as cirrhosis. We intended to determine the incidence of HEV infection among HIV-1 patients compared to individuals without HIV-1 infection. METHODS: In our cross-sectional study, 87 HIV-1-positive patients were compared to 93 healthy individuals in Kerman, Iran. Plasma and peripheral blood mononuclear cells (PBMCs) were obtained from all the participants. Plasma samples were evaluated for HEV IgM and IgG using the ELISA kit. Then, reverse transcriptase-nested polymerase chain reaction (RT-nested PCR) was used in RNA extractions from PBMCs to check for the presence of HEV RNA. RESULTS: Among the subjects examined in our study, 61 (70.1%) and 71 (77.4%) out of patients with HIV-1 infection and healthy individuals were male, respectively. The average ages of patients with HIV-1 and the control group were 40.2 years and 39.9 years, respectively. No discernible differences were found between the two groups based on IgM and IgG seropositivity against the HEV. However, HEV-RNA was found in 8% of patients with HIV-1 and 1.1% of HIV-1-negative individuals (P=0.03). There was also an association between the HEV genome and anti-HEV and anti-HCV antibodies in HIV-1-positive patients (P=0.02 and P=0.014, respectively). CONCLUSION: HEV infection may be more common in HIV-1 patients and may develop a chronic infection in immunocompromised individuals. Molecular-based HEV diagnostic tests, including RT-PCR assays, should be performed in HIV-1 patients with unknown impaired liver function tests.
format Online
Article
Text
id pubmed-10439753
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Iranian Society of Pathology
record_format MEDLINE/PubMed
spelling pubmed-104397532023-08-20 Higher Risk of Chronic Hepatitis E Virus Infection in Patients with Human Immunodeficiency Virus-1: An Iranian Cross-sectional Study Zahedi, Mohammad Javad Shafieipour, Sara Hayatbakhsh Abassi, Mohammad Mahdi Pourjamali, Nader Nakhaie, Mohsen Charostad, Javad Rezaei Zadeh Rukerd, Mohammad Lashkarizadeh, Mohammad Mehdi Karami Robati, Fatemeh Dehghani, Azam Jahani, Yunes Arabzadeh, Seyed Ali Mohammad Mollaei, Hamid Reza Ranjbar, Ebrahim Iran J Pathol Original Article BACKGROUND & OBJECTIVE: Occurrence of Hepatitis E Virus (HEV) infection may be common in Human Immunodeficiency Virus (HIV-1) patients and may lead to chronic infection as well as cirrhosis. We intended to determine the incidence of HEV infection among HIV-1 patients compared to individuals without HIV-1 infection. METHODS: In our cross-sectional study, 87 HIV-1-positive patients were compared to 93 healthy individuals in Kerman, Iran. Plasma and peripheral blood mononuclear cells (PBMCs) were obtained from all the participants. Plasma samples were evaluated for HEV IgM and IgG using the ELISA kit. Then, reverse transcriptase-nested polymerase chain reaction (RT-nested PCR) was used in RNA extractions from PBMCs to check for the presence of HEV RNA. RESULTS: Among the subjects examined in our study, 61 (70.1%) and 71 (77.4%) out of patients with HIV-1 infection and healthy individuals were male, respectively. The average ages of patients with HIV-1 and the control group were 40.2 years and 39.9 years, respectively. No discernible differences were found between the two groups based on IgM and IgG seropositivity against the HEV. However, HEV-RNA was found in 8% of patients with HIV-1 and 1.1% of HIV-1-negative individuals (P=0.03). There was also an association between the HEV genome and anti-HEV and anti-HCV antibodies in HIV-1-positive patients (P=0.02 and P=0.014, respectively). CONCLUSION: HEV infection may be more common in HIV-1 patients and may develop a chronic infection in immunocompromised individuals. Molecular-based HEV diagnostic tests, including RT-PCR assays, should be performed in HIV-1 patients with unknown impaired liver function tests. Iranian Society of Pathology 2023 2023-06-20 /pmc/articles/PMC10439753/ /pubmed/37600571 http://dx.doi.org/10.30699/IJP.2023.551657.2870 Text en https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution- 4.0 International License (https://creativecommons.org/licenses/by/4.0/) which permits Share, copy and redistribution of the material in any medium or format or adapt, remix, transform, and build upon the material for any purpose, even commercially.
spellingShingle Original Article
Zahedi, Mohammad Javad
Shafieipour, Sara
Hayatbakhsh Abassi, Mohammad Mahdi
Pourjamali, Nader
Nakhaie, Mohsen
Charostad, Javad
Rezaei Zadeh Rukerd, Mohammad
Lashkarizadeh, Mohammad Mehdi
Karami Robati, Fatemeh
Dehghani, Azam
Jahani, Yunes
Arabzadeh, Seyed Ali Mohammad
Mollaei, Hamid Reza
Ranjbar, Ebrahim
Higher Risk of Chronic Hepatitis E Virus Infection in Patients with Human Immunodeficiency Virus-1: An Iranian Cross-sectional Study
title Higher Risk of Chronic Hepatitis E Virus Infection in Patients with Human Immunodeficiency Virus-1: An Iranian Cross-sectional Study
title_full Higher Risk of Chronic Hepatitis E Virus Infection in Patients with Human Immunodeficiency Virus-1: An Iranian Cross-sectional Study
title_fullStr Higher Risk of Chronic Hepatitis E Virus Infection in Patients with Human Immunodeficiency Virus-1: An Iranian Cross-sectional Study
title_full_unstemmed Higher Risk of Chronic Hepatitis E Virus Infection in Patients with Human Immunodeficiency Virus-1: An Iranian Cross-sectional Study
title_short Higher Risk of Chronic Hepatitis E Virus Infection in Patients with Human Immunodeficiency Virus-1: An Iranian Cross-sectional Study
title_sort higher risk of chronic hepatitis e virus infection in patients with human immunodeficiency virus-1: an iranian cross-sectional study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439753/
https://www.ncbi.nlm.nih.gov/pubmed/37600571
http://dx.doi.org/10.30699/IJP.2023.551657.2870
work_keys_str_mv AT zahedimohammadjavad higherriskofchronichepatitisevirusinfectioninpatientswithhumanimmunodeficiencyvirus1aniraniancrosssectionalstudy
AT shafieipoursara higherriskofchronichepatitisevirusinfectioninpatientswithhumanimmunodeficiencyvirus1aniraniancrosssectionalstudy
AT hayatbakhshabassimohammadmahdi higherriskofchronichepatitisevirusinfectioninpatientswithhumanimmunodeficiencyvirus1aniraniancrosssectionalstudy
AT pourjamalinader higherriskofchronichepatitisevirusinfectioninpatientswithhumanimmunodeficiencyvirus1aniraniancrosssectionalstudy
AT nakhaiemohsen higherriskofchronichepatitisevirusinfectioninpatientswithhumanimmunodeficiencyvirus1aniraniancrosssectionalstudy
AT charostadjavad higherriskofchronichepatitisevirusinfectioninpatientswithhumanimmunodeficiencyvirus1aniraniancrosssectionalstudy
AT rezaeizadehrukerdmohammad higherriskofchronichepatitisevirusinfectioninpatientswithhumanimmunodeficiencyvirus1aniraniancrosssectionalstudy
AT lashkarizadehmohammadmehdi higherriskofchronichepatitisevirusinfectioninpatientswithhumanimmunodeficiencyvirus1aniraniancrosssectionalstudy
AT karamirobatifatemeh higherriskofchronichepatitisevirusinfectioninpatientswithhumanimmunodeficiencyvirus1aniraniancrosssectionalstudy
AT dehghaniazam higherriskofchronichepatitisevirusinfectioninpatientswithhumanimmunodeficiencyvirus1aniraniancrosssectionalstudy
AT jahaniyunes higherriskofchronichepatitisevirusinfectioninpatientswithhumanimmunodeficiencyvirus1aniraniancrosssectionalstudy
AT arabzadehseyedalimohammad higherriskofchronichepatitisevirusinfectioninpatientswithhumanimmunodeficiencyvirus1aniraniancrosssectionalstudy
AT mollaeihamidreza higherriskofchronichepatitisevirusinfectioninpatientswithhumanimmunodeficiencyvirus1aniraniancrosssectionalstudy
AT ranjbarebrahim higherriskofchronichepatitisevirusinfectioninpatientswithhumanimmunodeficiencyvirus1aniraniancrosssectionalstudy